Senior insider sale
Chief Medical Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$63.5K
19.35K shares
What this filing means
SIMS KAREN plans to sell 19.35K shares of ARBUTUS BIOPHARMA CORP valued at approximately $63.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2025ACC: 0001447028-25-000031
Officer· Chief Medical Officer
Since Jul 2023
19.35K
Shares to sell
$63.5K
Approx. market value
19.35K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
2/3/2025
19.35KTotal acquired19.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2025 | Restricted Stock Unit Vesting Compensation | 19.35K | — |
| Total | 19.35K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
19.35K
Market value
$63.5K
2/4/2025
Total
Units
19.35K
Value
$63.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/4/2025 | 19.35K | $63.5K | NASDAQ | Planned |
| Total | 19.35K | $63.5K | ||